Drug-induced glycosaminoglycan storage: Dose-dependent changes in the pattern of accumulated glycosaminoglycans in cultured bovine and human fibroblasts

Biochemical Pharmacology

Volumn 52, Issue 9, 1996, Pages 1331-1337

  Fischer, Jens ^a,b  

^a UNIVERSITY OF KIEL   (Germany)

^b NONE   (Germany)

Author keywords

dermatan sulfate; dicationic amphiphilic drugs; glycosaminoglycans; lysosomal storage; lysosomotropic agents; tilorone

Indexed keywords

2,6 BIS(2 DIETHYLAMINOETHOXY) 9,10 ANTHRAQUINONE; AMPHOPHILE; CATION; CHONDROITIN SULFATE; CL 90100; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; IMMUNOMODULATING AGENT; RMI 10223; TILORONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATTLE; CELL CULTURE; CELL DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA CELL; CYTOTOXICITY; DRUG INDUCED DISEASE; FIBROBLAST; HUMAN; HUMAN CELL; LYSOSOME; MUCOPOLYSACCHARIDOSIS; NONHUMAN; PERIODONTIUM; PRIORITY JOURNAL; STORAGE DISEASE;

ACRIDINES; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTHRAQUINONES; CATTLE; CELLS, CULTURED; DERMATAN SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; FIBROBLASTS; FLUORENES; GLYCOSAMINOGLYCANS; HUMANS; INTRACELLULAR FLUID; TILORONE;

EID: 0030575947     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00387-5     Document Type: Article

References (25)

1. 1. Hascall VC, Heinegard DK and Wight TN, Proteoglycans, Metabolism and pathology. In: Cell Biology of Extracellular Matrix (Eds, Hay ED) pp. 149-175. Plenum Press, New York, 1991.
2. 2. Chandra P and Wright GJ, Tilorone hydrochloride: the drug profile. Top Curr Chem 72: 125-148, 1977.
3. 3. Angier RB, Citarella RV, Damiami M, Fabio PF, Fields TL, Kang SM, Lin Y, Linch HF, Murdock KC, Petty SR, Wilkinson RG and Lang SA, Synthesis of 3,6-bis(amino-alkoxy)acridines and their effect on the immune system. J Med Chem 26: 1710-1715, 1983.
4. 4. Regelson W, The biological activity of the synthetic polyanion, pyran copolymer (Diveema, MVE, 46015) and the heterocyclic bis DEAE fluorenone derivative, tilorone and congeners: clinical and laboratory effects of these agents as modulators of host resistance. Pharmac Ther 15: 1-44, 1981.
5. 5. Hein L and Lüllmann-Rauch R, Mucopolysaccharidosis and lipidosis in rats treated with tilorone analogues. Toxicology 58: 145-154, 1989.
6. 6. Grave S, Lüllmann H, Lüllmann-Rauch R, Osterkamp G and Prokopek M, Induction of mucopolysaccharidosis in rats by treatment with immunostimulatory acridine derivatives. Toxicol Appl Pharmacol 114: 215-224, 1992.
7. 7. Prokopek M, The tilorone-induced mucopolysaccharidosis in rats. Biochem Pharmacol 42: 2187-2191, 1991.
8. 8. Burmester J, Handrock K and Lüllmann-Rauch R, Cultured corneal fibroblasts as a model system for the demonstration of drug-induced mucopolysaccaridosis. Arch Toxicol 64: 291-298, 1990.
9. 9. Lüllmann-Rauch R and Ziegenhagen M, Drug-induced lysosomal storage of sulfated glycosaminoglycans in cultured bovine and human fibroblasts. Virchows Arch [Zellpathol] 60: 99-104, 1991.
10. 10. Handrock K, Lüllmann-Rauch R and Vogt R, Drug-induced lysosomal storage of sulfated glycosaminoglycans. Studies on the underlying structure activity relationships. Toxicology 85: 199-213, 1993.
11. 11. Handrock K, Laschke A, Lüllmann-Rauch R, Vogt RD and Ziegenhagen M, Lysosomal storage of sulfated glycosaminoglycans in cultured fibroblasts exposed to immunostimulatory acridine derivatives. Toxicol Appl Pharmacol 114: 204-214, 1992.
12. 12. Fischer J, Degradation of free galactosaminoglycan chains is inhibited by two immunomodulatory compounds in cultured fibroblasts. Naunyn Schmiedebergs Arch Pharmacol 353, Supp R78, 1996.
13. 13. Fischer J, Tilorone-induced lysosomal storage of glycosaminoglycans in cultured corneal fibroblasts: Biochemical and physicochemical investigations. Biochem J 312: 215-222, 1995.
14. 14. Gupta DK, Gieselmann V, Hasilik A and von Figura K, Tilorone acts as a lysosomotropic agent in fibroblasts. Hoppe Seyler's Z Physiol Chem 365: 859-866, 1984.
15. 15. Lüllmann-Rauch R, Pods R and Von Witzendorff B, Tilorone-induced lysosomal storage of sulfated glycosaminoglycans can be separated from tilorone-induced enhancement of lysosomal enzyme secretion. Biochem Pharmacol 49: 1223-1233, 1995.
16. 16. Wessler E, Analytical and preparative separation of acidic glycosaminoglycans by electrophoresis in barium acetate. Anal Biochem 26: 439-444, 1968.
17. 17. Bleckmann H and Kresse H, Beeinflussung der Glycosaminoglycansynthese von kultivierten Stromazellen aus Rindercorneae durch Variation dur Kulturbedingungen. Albrecht v Graefes Arch klin exp Ophthal 210: 291-300, 1979.
18. 18. Bleckmann H and Kresse H, Glycosaminoglycan metabolism of cultured cornea cells derived from bovine and human stroma and from bovine epithelium. Exp Eye Res 30: 469-479, 1980.
19. 19. Habuchi H, Yamagata T, Iwata H and Suzuki S, The occurrence of a wide variety of dermatan sulfate-chondroitin sulfate copolymers in fibrous cartilage. J Biol Chem 248: 6019-6028, 1973.
20. 20. Yue BY, Baum JL and Silbert JE, The synthesis of glycosaminoglycans by cultures of rabbit corneal endothelial and stroma cells. Biochem J 158: 567-573, 1976.
21. 21. Axelsson I and Heinegard D, Fractionation of proteoglycans from bovine corneal stroma. Biochem J 145: 491-500, 1975.
22. 22. Larjava H, Häkkinen L, Rahemtulla F, A biochemical analysis of human peridontal tissue proteoglycans. Biochem J 284: 267-274, 1992.
23. 23. Seglen PO, Inhibitors of lysosomal function. Meth Enzymol 96: 737-764, 1983.
24. 24. Gonzalez-Noriega A, Grubb JH, Talkad V and Sly WS, Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling. J Cell Biol 85: 839-853, 1980.
25. 25. MacIntyre AC and Cutler DJ, The potential role of lysosomes in tissue distribution of weak bases. Biopharm Drug Dispos 9: 513-526, 1988.